Real-Time Blood Glucose CGM Patch Market CAGR Forecast Through 2030: Key Trends Shaping Industry Expansion
Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Revenue Growth On Track For A 14.5% CAGR Through 2030
The real-time blood glucose continuous glucose monitoring (cgm) patch market has experienced rapid expansion in recent years. Its size is projected to increase from $7.04 billion in 2025 to $8.08 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.8%. The historical growth of this market can be attributed to the rising incidence of diabetes, enhanced awareness of glucose self-monitoring, increased adoption of wearable medical devices, the expansion of hospital-based diabetes management, and improvements in sensor accuracy.
The real-time blood glucose continuous glucose monitoring (cgm) patch market is projected to experience substantial expansion over the upcoming years. Its size is anticipated to reach $13.89 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.5%. This projected growth during the forecast period is attributable to several factors, including the integration of real-time data analytics, the increasing uptake of telehealth, a growing demand for personalized diabetes management solutions, the expansion of homecare diagnostics, and rising investments in continuous monitoring technologies. Key trends observed during this period encompass the increasing adoption of patch-based glucose monitoring systems, a heightened demand for real-time glucose visibility, a noticeable shift towards non-invasive and minimally invasive monitoring methods, the expansion of home-based diabetes management strategies, and a greater utilization of continuous monitoring for early diagnosis.
Get A Free Sample Report With In-Depth Market Insights:
Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Demand Drivers Opening New Revenue Streams
The increasing occurrence of diabetes is anticipated to drive the expansion of the real-time blood glucose continuous glucose monitoring (CGM) patch market in the future. Diabetes is defined as a chronic metabolic condition characterized by elevated blood glucose levels, resulting from either insufficient insulin production or insulin resistance. The prevalence of diabetes is escalating as growing obesity leads to higher insulin resistance, which in turn disrupts blood sugar regulation and significantly raises the risk of developing type 2 diabetes. The real-time blood glucose continuous glucose monitoring (CGM) patch enables individuals with diabetes to continuously monitor their blood glucose levels in real time, offering timely alerts for hyperglycemia or hypoglycemia. This empowers them to make informed adjustments to their diet, medication, and lifestyle, ultimately enhancing overall disease management and reducing the potential for complications. For example, in June 2024, according to the National Health Service, a UK-based government department, 2023 saw the NHS identify over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes. This brought the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP, to 3,615,330. This figure signifies a notable rise compared to 3,065,825 in 2022, reflecting an increase of nearly 20%. Consequently, the rising prevalence of diabetes is propelling the growth of the real-time blood glucose continuous glucose monitoring (CGM) patch market.
Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Segmentation And Category Overview
The real-time blood glucose continuous glucose monitoring (cgm) patch market covered in this report is segmented –
1) By Product Type: Wearable Continuous Glucose Monitoring (CGM) Patch, Implantable Continuous Glucose Monitoring (CGM) Patch
2) By Technology: Enzymatic, Non-Enzymatic
3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels
4) By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Other Applications
5) By End User: Hospitals And Clinics, Homecare Settings, Diagnostic Centers, Other End Users
Subsegments:
1) By Wearable Continuous Glucose Monitoring (CGM) Patch: Sensor-Embedded Wearable Continuous Glucose Monitoring (CGM) Patch, Bluetooth-Enabled Wearable Continuous Glucose Monitoring (CGM) Patch, Mobile-Connected Wearable Continuous Glucose Monitoring (CGM) Patch
2) By Implantable Continuous Glucose Monitoring (CGM) Patch: Subcutaneous Implantable Continuous Glucose Monitoring (CGM) Patch, Long-Term Implantable Continuous Glucose Monitoring (CGM) Patch, Miniaturized Implantable Continuous Glucose Monitoring (CGM) Patch
Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Trends Powering Strategic Industry Growth
Major companies operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are prioritizing the development of innovative products, such as over-the-counter continuous glucose monitoring sensors, to broaden access and enhance user convenience. These over-the-counter continuous glucose monitoring (CGM) sensors are wearable devices that meticulously track glucose levels in real time and are available for purchase without a prescription, thereby empowering users to continuously monitor their glucose, comprehend the influence of lifestyle factors on their levels, and more easily manage or prevent diabetes. For instance, in September 2024, Dexcom Inc., a US-based diabetes technology company, introduced Stelo, its inaugural over-the-counter (OTC) continuous glucose monitoring (CGM) patch in the United States. This compact, wearable sensor is affixed to the back of the upper arm, supplying real-time glucose readings directly to a smartphone application without requiring fingersticks. Specifically designed for individuals with Type 2 diabetes who do not use insulin and those with prediabetes, Stelo provides personalized insights into how diet, exercise, and sleep impact glucose levels. The device offers up to 15-day wear time, is waterproof, features spike and pattern detection, and integrates with Dexcom’s established glucose sensing technology, thereby rendering continuous glucose monitoring more accessible, convenient, and actionable for a wider population.
Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Key Participants And Competitive Landscape
Major companies operating in the real-time blood glucose continuous glucose monitoring (cgm) patch market are Abbott Laboratories, Dexcom Inc., Medtronic plc, Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., MicroTech Medical Inc., Zhejiang POCTech Co. Ltd., SiBio Technology Co. Ltd., Metronom Health Inc., Nemaura Medical Inc., PKvitality SAS, Nutromics Ltd., EOFlow Co. Ltd., i-SENS Inc., Sinocare Inc., Afon Technology Ltd., LifePlus Inc., Ultrahuman Healthcare Pvt. Ltd., Roche Diabetes Care AG, Ascensia Diabetes Care Holdings AG
View The Full Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Report:
Real-Time Blood Glucose Continuous Glucose Monitoring (CGM) Patch Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose continuous glucose monitoring (cgm) patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
